Fennec Pharmaceuticals (FENC)

• Market cap: $243M
• 1 day: 0.69%
• 5 days: 4.56%
• 1 month: 0.58%
• 3 months: 3.69%
• 6 months: 67.37%
• Year to date: 38.63%
• 1 year: 87.12%
• 5 years: 19.45%
• 10 years: -27.33%
• Sector: Healthcare
• Industry: Biotechnology

About: Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Employees: 32